Cancer Trial Results
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial - The Lancet Oncology
Dr. STEFANY CARDOSO FARIA - MÉDICO ONCOLOGISTA: #ASCO 2017 Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20
Cancers | Free Full-Text | Investigating the Impact of Ultra-Radical Surgery on Survival in Advanced Ovarian Cancer Using Population-Based Data in a Multicentre UK Study
Secondary cytoreductive surgery for recurrent ovarian cancer improves overall survival - BJMO
PPT - An Oncology Exchange Activity PowerPoint Presentation, free download - ID:5600388
AGO-OVAR DESKTOP III (Protocol AGO - OVAR OP.4) - ppt video online download
تويتر \ Shannon Westin على تويتر: "Cross trial comparisons are always tricky...but, comparing the survival curves between the trials gives great pause - the GOG213 medians are markedly higher. Many thanks to @
DESKTOP III: Surgery in PSROC - Slideset Download - Clin Onc 2020 | CCO
When should Surgery be used for Recurrent Ovarian Carcinoma? - ScienceDirect
Presentación de PowerPoint
Cancer Trial Results
Frontiers | Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer
Design of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian... | Download Scientific Diagram
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer | NEJM
Journal of Gynecologic Oncology
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer | NEJM
Epithelial ovarian cancer - The Lancet
توییتر \ Shannon Westin در توییتر: «DESKTOP III demonstrated improved PFS and OS for patients that underwent surgery for recurrent #ovariancancer #ASCO20 #SGOatASCO #gyncsm https://t.co/z0dEmwPzOk»
AGO-OVAR DESKTOP III (Protocol AGO - OVAR OP.4) - ppt video online download
Ovarian cancer surgery | SpringerLink
Presentación de PowerPoint
Randomized Trial of Cytoreductive Surgery for Relapsed Ovarian Cancer | NEJM
Shannon Westin on Twitter: "Patient selection clearly matters - DESKTOP III used the AGO criteria, SOC-1 used iMODEL score - both have been validated to predict ability to achieve complete resection -
